Evidence-based resources

Gray-market peptides, bioactive peptides
and GLP-1s
what the research says

Every fact on this page is sourced directly from peer-reviewed clinical research. No opinions. Just the science.

Medical disclaimer: This page is for educational purposes only. Nothing here constitutes medical advice. Always consult a licensed physician before making decisions about medications or supplements.
~18%
Average weight loss with tirzepatide in clinical trials
NEJM SURMOUNT-1, 2022
9.7 kg
Average weight regained after stopping GLP-1 therapy
BMJ meta-analysis, 2025
23%
Of online peptide products are contaminated or mislabeled
Peptides journal, 2023
Section 01
Gray-market peptides
Regulatory status
0
FDA-approved human uses for BPC-157, TB-500, and CJC-1295
The peptides trending on social media have not been approved for human use by the FDA or Health Canada. They are sold as "research chemicals" to avoid regulatory oversight. Any human use is entirely off-label with no studied clinical data in human populations.
Product safety
23%
Of online peptide products are contaminated or mislabeled
Independent analysis found nearly one in four products failed quality testing.
Market trend
208%
Increase in online ads for unregulated peptides in 2024
Social media posts promoting sales grew 75% year over year in the same period.
⚠️
BPC-157 promotes angiogenesis, the growth of new blood vessels. This is also the primary mechanism tumors use to establish blood supply and spread. No long-term human safety data exists to evaluate this risk.
Route of administration
Why injection changes everything
Water is safe to drink. However, injecting water directly into the bloodstream in sufficient volume can cause fatal hemolysis — the rupturing of red blood cells. This illustrates a core principle of pharmacology: a substance that is safe or beneficial by one route can be dangerous or fatal by another. Gray-market peptides are predominantly injectable, often from unverified sources, in unstudied human doses. The same compound that appears benign in an oral animal study carries an entirely different risk profile when injected without medical supervision.
Source: Basic pharmacology and toxicology principles; Journal of Emergency Medicine, 2019
🔬
Evidence base: The vast majority of research cited for gray-market peptides comes from rodent studies. Results from animal models do not reliably translate to human outcomes. No trending peptide has completed a phase 3 human clinical trial. Testimonials are not clinical evidence.
Section 02
GLP-1 receptor agonists
FDA approved
What GLP-1s actually are
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are legitimate FDA-approved prescription medications developed for type 2 diabetes and obesity management. They have been studied in tens of thousands of patients across 40+ phase 3 clinical trials. These are not supplements and are not comparable to gray-market peptides.
Efficacy
~12%
Average weight loss with semaglutide vs placebo
From the STEP 1 trial, the largest of its kind.
Efficacy
~18%
Average weight loss with tirzepatide vs placebo
From the SURMOUNT-1 trial. Highest efficacy recorded for any non-surgical obesity intervention.
After stopping
9.7 kg
Average weight regained after stopping GLP-1 therapy
A 2025 systematic review and meta-analysis found stopping semaglutide or tirzepatide led to an average regain of 9.7 kg. Real-world data shows approximately two thirds of lost weight returns within six months. An Oxford study projected return to baseline weight within approximately 1.5 years of stopping. Blood pressure, cholesterol, and blood sugar improvements also reverse in proportion to weight regained. Current clinical guidelines increasingly classify obesity as a chronic condition requiring long-term pharmacological management rather than a short-term course of treatment.
Clinical criteria
Who these medications were designed for
FDA and WHO guidelines indicate pharmacological treatment for individuals with a BMI of 30 or higher, or BMI 27 or higher with at least one weight-related condition such as type 2 diabetes, hypertension, high cholesterol, or obstructive sleep apnea. All clinical trials that produced the efficacy numbers above studied these populations specifically. There are no completed clinical trials examining outcomes in healthy-weight individuals without metabolic conditions.
⚠️
Compounded and influencer versions: Compounded GLP-1 products sold online or via unvetted telehealth providers do not undergo FDA safety or quality review. GLP-1 patches promoted on social media are not supported by pharmacokinetic evidence. GLP-1 molecules cannot be absorbed through the skin. Microdosing protocols have not demonstrated therapeutic plasma concentrations in any published research.
Section 03
Side by side comparison
Factor
GLP-1 drugs
Gray-market peptides
FDA approved
Yes
No
Human clinical trial data
Extensive (40+ trials)
Essentially none
Requires prescription
Yes
Sold as research chemicals
Known side effects
Well documented
Unknown long-term
Product purity guaranteed
Yes (branded)
Up to 23% contaminated
Evidence in healthy-weight individuals
None
None
Approved in competitive sport
Not prohibited
WADA prohibited list
Section 04
Bioactive peptides
What they are
Your body produces bioactive peptides naturally from dietary protein
Peptides are not only found in injectable vials sold online. Every time you eat protein-rich food, your digestive system breaks those proteins down into smaller chains of amino acids called bioactive peptides. These peptides are released during digestion and play real, documented roles in your body including regulating blood pressure, supporting immune function, influencing appetite and satiety, and contributing to muscle protein synthesis. This process is continuous, natural, and requires no supplementation of any kind.
Protein intake and peptide production
The amount and quality of protein you eat directly determines your body's bioactive peptide output
Research consistently shows that adequate dietary protein intake of 1.6 to 2.2g per kg of bodyweight per day provides the raw material your body needs to generate bioactive peptides through digestion. Animal proteins including meat, fish, eggs and dairy, as well as plant proteins from legumes, soy and grains, all produce different peptide profiles with different physiological effects. The specific peptides released depend on the protein source, how it is prepared, and your individual digestive enzymes. No injectable compound can replicate the complexity and safety of this natural process.
Animal sources
Best dietary sources of bioactive peptides
Eggs, dairy (whey and casein), fish, chicken, beef and pork all produce well-studied bioactive peptides on digestion. Whey protein in particular is among the most researched sources for muscle protein synthesis and satiety-related peptides.
Plant sources
Plant proteins also produce bioactive peptides
Soy, peas, lentils, chickpeas, quinoa and walnuts all generate bioactive peptides during digestion with documented roles in blood pressure regulation, antioxidant activity and appetite management.
💡
The takeaway: Before spending hundreds of dollars per month on injectable compounds with no human safety data, optimizing your dietary protein intake is the single most evidence-backed way to support your body's natural peptide production. Whole food first, always.
Section 05
What the evidence actually supports
Evidence-based foundations
For most people, the fundamentals have the strongest evidence base
Decades of peer-reviewed research consistently support resistance training for body composition, muscle preservation, and metabolic health. Adequate protein intake (1.6 to 2.2g per kg of bodyweight) supports muscle protein synthesis and satiety. Quality sleep of 7 to 9 hours regulates the hunger hormones ghrelin and leptin. Creatine monohydrate remains one of the most studied and consistently effective supplements available. These interventions have no dependency risk, no unknown contamination, and no requirement for ongoing pharmaceutical use to maintain results.
🩺
Always speak to your physician first
Every individual's health situation is different. The research on this page applies to studied populations under clinical conditions. Before considering any medication, supplement, or injectable compound, consult a licensed physician who knows your full medical history. This page is educational only and does not constitute medical advice of any kind.